Skip to main content
CHARM 2023
Times are shown in your local time zone GMT

Restricting access to antibiotics: the effectiveness of a ‘no repeats’ government policy intervention

On Demand

On Demand

2:20 pm

20 July 2023

Room 2

ACT research in focus: Stream 6

Talk Description

Background
Australia has a high rate of antibiotic use. Government policy interventions are one strategy to optimise the use of antibiotics. On 1 April 2020, the Australian Government Department of Health introduced a policy intervention to increase the quality use of four antibiotics.
 
Objectives 
To assess if the government policy intervention improved the appropriate supply of the four antibiotics amoxicillin, amoxicillin-clavulanic acid, cefalexin and roxithromycin.
 
Method
This study employed a retrospective cohort study design comparing a 10% sample (n = 345,018) of four antibiotics prescribed and dispensed in Australia during a three-month period (May, June, July) in 2019, and again in 2020 (after the policy intervention). The 10% sample of PBS data was obtained from the Australian Government Department of Health. Descriptive statistics, bivariate and multivariable logistic regression analysis were carried out. 
 
Results 
The results suggest the policy change improved the appropriate supply of original prescriptions in 2020 compared to 2019 OR = 1.75 (95% CI = 1.68-1.82, p<0.001), and appropriate supply of repeat prescriptions OR = 1.56 (95% CI = 1.25-1.96, p<0.001). In 2020, the proportion of appropriate supply of original prescriptions increased by an absolute difference of 1.8% (95% CI = 1.6-1.9%; P<0.001), and appropriate supply of repeat prescriptions increased by 3.9% (95% CI = 2.2-5.5%; P<0.001). 
 
Conclusion 
The study provides evidence for the impact of a government policy intervention to improve the appropriate supply of antibiotics, although some of the reduction in antibiotic use was likely due to the concomitant COVID-19 pandemic. 
 
Significance
This supports the use of government policy interventions as an effective antimicrobial stewardship intervention.
 
 
Juliet Contreras1, Victor Oguoma2, Lyn Todd1, Mark Naunton1, Peter Collignon3,4, Mary Bushell1
 
 
1.     Faculty of Pharmacy, University of Canberra, Bruce, ACT, 2617
2.     Health Research Institute, University of Canberra, Bruce, ACT, 2617
3.     ANU Medical School, ANU College of Health & Medicine, The Australian National University, Canberra, ACT, 2601
4.     Australian Capital Territory Pathology, Canberra Hospital, Garran, Canberra, ACT, 2605

Presenters

Authors

Presenting Authors

Juliet Contreras -